Introduction: Human chorionic gonadotropin B (betahCG) can be rarely expressed by non-trophoblastic tumors of the bladder, breast, lung, gastrointestinal tract, etc. We report a rare case of a young woman worked up for pregnancy due to elevated beta-hCG, incidentally revealed to have metastatic adenocarcinoma in the liver. Case Summary: A 39-year-old Hispanic woman presented with abdominal pain and positive urine pregnancy test. Serum beta-hCG was elevated at 127 mIU/mL and rose to 1,081 mIU/mL in a month; however, no gestational sac was identified on imaging. CT showed multiple hypoechoic liver masses (the largest 4.2 cm in segment 8) and an irregularly thickened gallbladder wall, suggestive of a metastatic process. Tumor markers were unremarkable, and alkaline phosphatase was 856 U/L. Fine needle aspiration (FNA) and touch smears displayed clusters of neoplastic cells with intracytoplasmic vacuoles. Core biopsy showed a tumor composed of nests and cords of pleomorphic cells with intracytoplasmic mucin and rare glandular arrangement consistent with adenocarcinoma. The tumor was positive for CK7 and CK17, and negative for CK20, compatible with biliary origin. Beta-hCG immunostain showed positive cytoplasmic staining in the tumor cells, confirming the source of elevated serum beta-hCG. Discussion: Follow-up revealed that the liver mass rapidly increased in number and size with more prominent gallbladder circumferential mass and nodularity, leading to death of the patient a month later. Immunohistochemistry confirmed strongly and diffusely beta-hCG expression in primary or metastatic cholangiocarcinoma has rarely been reported.
Conclusion:
We describe an interesting case of cholangiocarcinoma with beta-hCG expression with a delay in diagnosis due to presumptive diagnosis of pregnancy in a young woman. Non-trophoblastic tumors should be considered in the differential diagnosis of a patient with elevated beta-hCG and no detectable pregnancy by imaging. Early treatment with chemotherapy has been reported to be beneficial in certain cases in the literature.
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Objectives: Perineural invasion is associated with poor prognosis and decreased survival in various malignancies. It is a feature that pathologists routinely search for and report. However, benign perineural Leydig cells can be observed in the paratesticular tissues. This phenomenon is a potential diagnostic pitfall, which may trigger an incorrect diagnosis of malignant perineural invasion. Our aim is to report a case of testicular mixed germ cell tumor with benign perineural Leydig cells in the spermatic cord, thereby drawing awareness to the potential diagnostic pitfall. Methods: This a retrospective review of a case of a 24-yearold man with a 3.0 cm mixed germ cell tumor of the right testicle. Histopathologic evaluation if the spermatic cord showed large cellular clusters within and along nerve bundles, suspicious for malignant perineural invasion. Results: Ultrasound imaging revealed a well-circumscribed, heterogenous 3.2 cm mass of the right testicle. CT of the chest, abdomen and pelvis showed no evidence of metastatic disease. Pre-operative lab results included the following: LDH 171 u/L, Beta-HCG 717 u/L, and AFP 90.3 ng/mL. Histopathology revealed a 3.0 cm mixed germ cell tumor (embryonal carcinoma 60%, teratoma 30%, yolk sac tumor 8%, choriocarcinoma 2%). The tumor was confined to the testicle without angiolymphatic
